Here are three updates from Xtant Medical so far in 2025.
1. Xtant Medical launched OsteoFactorPro, a naturally derived, growth factor-rich formulation for spine and orthopedics. OsteoFactorPro is designed to enhances the biologic activity and regenerative potential of any orthobiologic scaffold.
2. Xtant Medical is selling certain Coflex and CoFix spinal implants and all OUS entities of Paradigm Spine GmbH to Companion Spine. The assets sold for $19.2 million, and Xtant Medical plans to use the money to reduce long-term debt and add to cash liquidity.
3. Xtant Medical’s second-quarter sales reached $35.4 million, according to financial results posted Aug. 12. The company saw net income of $3.6 million compared to a net loss of $3.9 million in the same time in 2024.
